What is the current Price Target for the Dr. Reddy's Laboratories Ltd. Sponsored ADR stock?

The average Dr. Reddy's Laboratories Ltd. Sponsored ADR target price is $14.81. This is 2.16% higher than the current stock price. The highest price target is 28.26%, the lowest is -18.42%. 32 Analysts have issued a price target Dr. Reddy's Laboratories Ltd. Sponsored ADR 2026 .

What's going on with the Dr. Reddy's Laboratories Ltd. Sponsored ADR stock today?

The performance of Dr. Reddy's Laboratories Ltd. Sponsored ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Dr. Reddy's Laboratories Ltd. Sponsored ADR Forecast, price target & analysts

Q: How high will the Dr. Reddy's Laboratories Ltd. Sponsored ADR stock rise?

No reliable answer can be given as to how high the Dr. Reddy's Laboratories Ltd. Sponsored ADR stock will rise. The performance of stocks, including the Dr. Reddy's Laboratories Ltd. Sponsored ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

Q: Why did the Dr. Reddy's Laboratories Ltd. Sponsored ADR stock fall?

The decline in Dr. Reddy's Laboratories Ltd. Sponsored ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

$14.50

0.28% yesterday

NYSE, May 20, 10:10 pm CET

ISIN

US2561352038

Symbol

RDY

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Dr. Reddy's Laboratories Ltd. Sponsored ADR Target price 2025 - Analyst rating & recommendation

Dr. Reddy's Laboratories Ltd. Sponsored ADR Classifications & Recommendation:

Buy

36%

Hold

30%

Sell

33%

Dr. Reddy's Laboratories Ltd. Sponsored ADR Price Target

Target Price	$14.81
Price	$14.50
Potential	2.16% register free of charge
Number of Estimates	32

	32 Analysts have issued a price target Dr. Reddy's Laboratories Ltd. Sponsored ADR 2026 . The average Dr. Reddy's Laboratories Ltd. Sponsored ADR target price is $14.81. This is 2.16% register free of charge higher than the current stock price. The highest price target is $18.60 28.26% register free of charge , the lowest is $11.83 18.42% register free of charge .
	A rating was issued by 33 analysts: 12 Analysts recommend Dr. Reddy's Laboratories Ltd. Sponsored ADR to buy, 10 to hold and 11 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Dr. Reddy's Laboratories Ltd. Sponsored ADR stock has an average upside potential 2026 of 2.16% register free of charge . Most analysts recommend the Dr. Reddy's Laboratories Ltd. Sponsored ADR stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Mar '25	2026 Estimates
Revenue Billion $	3.82	4.13
	16.54%	7.28%
EBITDA Margin	26.70%	25.97%
	5.72%	1.96%

32 Analysts have issued a sales forecast Dr. Reddy's Laboratories Ltd. Sponsored ADR 2026 . The average Dr. Reddy's Laboratories Ltd. Sponsored ADR sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2025	$3.8b	16.54%
2026	$4.1b 7.28% Unlock
2027	$4.1b 0.43% Unlock
2028	$4.5b 9.22% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Mar '25	2026 Estimates
Earnings Per Share $	0.79	0.83
	1.28%	3.75%
P/E		17.51
EV/Sales		2.90

20 Analysts have issued a Dr. Reddy's Laboratories Ltd. Sponsored ADR forecast for earnings per share. The average Dr. Reddy's Laboratories Ltd. Sponsored ADR EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2025	$0.79	1.28%
2026	$0.83 3.75% Unlock
2027	$0.67 19.28% Unlock
2028	$0.72 7.46% Unlock

Current	18.08	7.05%
2026	17.51 3.15% Unlock
2027	21.58 23.24% Unlock
2028	20.04 7.14% Unlock

Based on analysts' sales estimates for 2026, the Dr. Reddy's Laboratories Ltd. Sponsored ADR stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	3.11	1.27%
2026	2.90 6.64% Unlock
2027	2.92 0.43% Unlock
2028	2.67 8.45% Unlock

Current	3.14	6.96%
2026	2.92 6.77% Unlock
2027	2.94 0.43% Unlock
2028	2.69 8.44% Unlock

Dr. Reddy's Laboratories Ltd. Sponsored ADR...

Discover more stocks with a high price target

BioNTech SE - ADR 32.27%

Alibaba Group Holding Ltd 29.91%

Tencent Holdings Ltd. 22.81%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now